Tos crónica resistente al tratamiento

1 Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet 2008; 371:1364-74.
2 Song WJ, Chang YS, Faruqi S, et al. The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 2015; 45:1479-81.
3 Janson C, Chinn S, Jarvis D, et al. Determinants of cough in young adults
participating in the European Community respiratory health survey. Eur Respir J 2001; 18:647-54.
4 Cerveri I, Accordini S, Corsico A, et al. Chronic cough and phlegm in young adults. Eur Respir J 2003; 22:413-7.
5 Coultas DB, Mapel D, Gagnon R, et al. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001; 164:372-7.
6 Ford AC, Forman D, Moayyedi P, et al. Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax 2006; 61:975-9.
7 Cullinan P. Persistent cough and sputum: prevalence and clinical characteristics in south east England. Respir Med 1992; 86:143-9.
8 Irwin R, Curley F, French C. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990; 141:640-7.
9 Schappert SM. National ambulatory medical care survey: 1991 summary. Vital Health Stat 1994; 13:1-110.
10 Britt H, Miller G, Charles J, et al. General practice activity in Australia 2006-2007. Australian Institute of Health and Welfare, 2008.
11 Zemp E, Elsasser S, Schindler C, et al. Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA Team. Am J Respir Crit Care Med 1999; 159:1257-66.
12 Di Pede C, Viegi G, Quackenboss JJ, et al. Respiratory symptoms and risk factors in an Arizona population sample of Anglo and Mexican-American whites. Chest 1991; 99:916-22.
13 Pavord I, Chung K. Management of chronic cough. Lancet 2008; 371:1375-84.
14 Morice AH, Jakes AD, Faruqi S, et al. A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J 2014;44:1149-55.
15 Everett C, Kastelik J, Thompson R, et al. Chronic persistent cough in the community: a questionnaire survey. Cough 2007; 3:5; doi:10.1186/1745-9974-3-5.
16 French C, Irwin R, Curley F, et al. Impact of chronic cough quality of life. Arch Intern Med 1998; 158:1657-61.
17 Chamberlain SA, Garrod R, Douiri A, et al. The impact of chronic cough: a cross-sectional European survey. Lung 2015; 193:401-8.
18 McGarvey L, Carton C, Gamble L, et al. Prevalence of psychomorbidity among patients with chronic cough. Cough 2006;2:4; doi:10.1186/1745-9974-2-4.
19 Dicpinigaitis PV, Tso R, Banauch G. Prevalence of depressive symptoms among patients with chronic cough. Chest J 2006; 130:1839-43.
20 Gibson PG, Wang G, McGarvey L, et al. Treatment of unexplained chronic cough: CHEST guideline and expert panel report. Chest 2015; doi:10.1378/chest.15-1496.
21 Irwin R, Boulet L, Cloutier M, et al. Managing cough as a defense mechanism and as a symptom: a consensus report for the American College of Chest Physicians. Chest 1998; 114:133S.
22 Morice A. The cough hypersensitivity syndrome: a novel paradigm for understanding cough. Lung 2010; 188(suppl 1):S87-90.
23 Chung KF. Approach to chronic cough: the neuropathic basis for cough hypersensitivity syndrome. J Thorac Dis 2014; 6(suppl 7):S699-707.
24 Morice AH, Millqvist E, Belvisi MG, et al. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J 2014; 44:1132-48.
25 Morice A, McGarvey L, Dicipinigaitis P. Cough hypersensitivity syndrome is an important clinical concept: a pro/con debate. Lung 2011; 190:3-9.
26 Ryan NM, Gibson PG. Characterization of laryngeal dysfunction in chronic persistent cough. Laryngoscope 2009; 119:640-5.
27 Vertigan AE, Theodoros DG, Winkworth AL, et al. Perceptual voice characteristics in chronic cough and paradoxical vocal fold movement. Folia Phoniatr Logopaed 2007; 59:256-67.
28 Vertigan AE, Theodoros DG, Gibson PG, et al. Voice and upper airway symptoms in people with chronic cough and paradoxical vocal fold movement. J Voice 2007; 21:361-83.
29 Vertigan A, Theodoros D, Gibson PG, et al. Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax 2006; 61:1065-9.
30 Hull JH, Menon A. Laryngeal hypersensitivity in chronic cough. Pulmon Pharmacol Ther 2015; doi:10.1016/j.pupt.2015.08.008.
31 Vertigan AE, Bone SL, Gibson PG. Development and validation of the Newcastle laryngeal hypersensitivity questionnaire. Cough 2014; 10:1; doi:10.1186/1745-9974-10-1.
32 Morrison M, Rammage L, Emami A. The irritable larynx syndrome. J Voice 1999;13:447-55.
33 Morrison M, Rammage L. The irritable larynx syndrome as a central sensitivity syndrome. Can J Speech Language Pathol Audiol 2010; 34:282-9.
34 Vertigan AE, Bone SL, Gibson PG. Laryngeal sensory dysfunction in laryngeal hypersensitivity syndrome. Respirology 2013; 18:948-56.
35 Andrianopoulous M, Gallivan G, Gallivan K. PVCM, PVCD, EPL and irritable larynx syndrome: what are we talking about and how do we treat it? J Voice 2000; 14:607-18.
36 Haque R, Usmani O, Barnes P. Chronic idiopathic cough: a discrete clinical entity? Chest 2005; 127:1710-3.
37 Abdullah H, Heaney LG, Cosby SL, et al. Rhinovirus upregulates transient receptor potential channels in a human neuronal cell line: implications for respiratory virus-induced cough reflex sensitivity. Thorax 2014; 69:46-54.
38 Canning BJ, Chang AB, Bolser DC, et al. Anatomy and neurophysiology of cough: chest guideline and expert panel report. Chest 2014; 146:1633-48.
39 Groneberg D, Niimi A, Dinh QT, et al. Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am Respir Crit Care Med 2004; 170:1276-80.
40 Khalid S, Murdoch R, Newlands A, et al. Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial. J Allergy Clin Immunol 2014;134:56-62.
41 Latremoliere A, Woolf C. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009; 10:895-926.
42 Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011; 152(3 suppl):18.
43 Vertigan A, Gibson P. Chronic refractory cough as a laryngeal sensory neuropathy: evidence from a reinterpretation of cough triggers. J Voice 2011; 25:596-601.
44 O’Neill J, McMahon S, Undem B. Chronic cough and pain: Janus faces in sensory neurobiology? Pulmon Pharmacol Ther 2010; 26:476-85.
45 Aviv JE, Kim T, Thomson JE, et al. Fiberoptic endoscopic evaluation of swallowing with sensory testing (FEESST) in healthy controls. Dysphagia 1998; 13:87-92.
46 Vertigan AE, Theodoros DG, Winkworth AL, et al. Chronic cough: a tutorial for speech-language pathologists. J Med Speech Language Pathol 2007; 15:189-206.
47 Mazzone S, McGovern AE, Yang S-K, et al. Sensorimotor circuitry involved in the higher brain control of coughing. Cough 2013;9:7; doi:10.1186/1745- 9974-9-7.
48 Leech J, Mazzone SB, Farrell MJ. Brain activity associated with placebo suppression of the urge-to-cough in humans. Am J Respir Crit Care Med 2013; 188:1069-75.
49 Ryan N, Birring S, Gibson P. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 2012; 380:1583-9.
50 Halum S, Sycamore D, McRae B. A new treatment option for laryngeal sensory neuropathy. Laryngoscope 2009; 119:1844-7.
51 Vertigan A, Kapela S, Birring SS. Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomised controlled trial. Chest 2015; doi:10.1378/chest.15-1271.
52 Morice AH, Menon MS, Mulrennan SA, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med 2007; 175:312-5.
53 Jeyakumar A, Brickman TM, Haben M. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope 2006;116: 2108-12.
54 Mazzone SB, McLennan L, McGovern AE, et al. Representation of capscaisin evoked urge to cough in human brain using functional MRI. Am J Respir Crit Care Med 2007; 176:327-32.
55 Mazzone SB, Mori N, Canning BJ. Synergistic interactions between airway afferent nerve subtypes regulating the cough reflex in guinea-pigs. J Physiol 2005; 569:559-73.
56 Pacheco A. Chronic cough: from a complex dysfunction of the neurological circuit to the production of persistent cough. Thorax 2014; 69:881-3.
57 Mathers-Schmidt B. Paradoxical vocal fold motion: a tutorial on a complex disorder and the speech-language pathologists role. Am J Speech Language Pathol 2001; 10:111-25.
58 Murry T, Tabaee A, Aviv J. Respiratory retraining of refractory cough and laryngopharyngeal reflux in patients with paradoxical vocal fold movement disorder. Laryngoscope 2004; 114:1341-5.
59 Morice AH, McGarvey L, Pavord I. Recommendations for the management of cough in adults. Thorax 2006; 61(suppl 1):i1-24.
60 Ryan NM, Vertigan AE, Ferguson JK, et al. Clinical and physiological features of postinfectious chronic cough associated with H1N1 infection. Respir Med 2012; 106:138-44.
61 Birrell MA, Bonvini SJ, Dubuis E, et al. Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: a beneficial off target effect? J Allergy Clin Immunol 2014; 133:679-87.
62 Prudon B, Birring S, Vara D, et al. Cough and glottic-stop reflex sensitivity in health and disease. Chest 2005; 127:550-7.
63 Cohen SM, Misono S. Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review. Otolaryngol Head Neck Surg 2013; 148:374-82.
64 McGarvey L. The difficult-to-treat, therapy-resistant cough: why are current cough treatments not working and what can we do? Pulm Pharmacol Ther 2013; 26:528-31.
65 Gibson P, Chang A, Glasgow N, et al. Cough in children and adults, diagnosis and assessment: Australian cough guidelines. Med J Aust 2010;192:265-71.
66 French CT, Diekemper RL, Irwin RS. Assessment of intervention fidelity and recommendations for researchers conducting studies on the diagnosis and treatment of chronic cough in the adult: CHEST guideline and expert panel report. Chest 2015; 148:32-54.
67 Forrest L, Husein T, Husein O. Paradoxical vocal cord motion: classification and treatment. Laryngoscope 2012; 122:844-53.
68 Vertigan A, Theodoros D, Winkworth A, et al. Acoustic and electroglottographic voice characteristics in chronic cough and paradoxical vocal fold movement. Folia Phoniatr Logopaed 2008; 60:210-6.
69 Altman KW, Noordzij JP, Rosen CA, et al. Neurogenic cough. Laryngoscope 2015; 125:1675-81.
70 Sarani B, Gleiber M, Evans SR. Esophageal pH monitoring, indications, and methods. J Clin Gastroenterol 2002; 34:200-6.
71 Smith JA, Decalmer S, Kelsall A, et al. Acoustic cough—reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology 2010; 139:754-62.
72 Birring S. Controversies in the evaluation and management of chronic cough. Am J Respir Crit Care Med 2011; 183:708-15.
73 Abdul-Hussein M, Freeman J, Castell DO. Cough and throat clearing: atypical
GERD symptoms or not GERD at all? J Clin Gastroenterol 2015; published online 18 Jul.
74 Chamberlain S, Garrod R, Birring S. Cough suppression therapy: does it work? Pulmon Pharmacol Ther 2013; 26:524-7.
75 Patel A, Watkin G, Willig B, et al. Improvement in health status following cough-suppression physiotherapy for patients with chronic cough. Chronic Respir Dis 2011; 8:253-8.
76 Ryan NM, Vertigan AE, Gibson PG. Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement. Cough 2009; 5:1-8.
77 Ryan NM, Vertigan AE, Bone S, et al. Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough. Cough 2010; 6:1-8.
78 Murry T, Branski R, Yu K, et al. Laryngeal sensory deficits in patients with chronic cough and paradoxical vocal fold movement disorder. Laryngoscope 2010; 120:1576-81.
79 Raj AA, Pavord DI, Birring SS. Clinical cough IV: what is the minimal important difference for the Leicester cough questionnaire? Handb Exp Pharmacol 2009; 187:311-20.
80 Davenport P, Sapienza C, Bolser D. Psychophysical assessment of the urge to cough. Eur Respir J 2002; 12:249-53.
81 Hilton E, Marsden P, Thurston A, et al. Clinical features of the urge-to cough in patients with chronic cough. Respir Med 2015; 109:701-7.
82 Murry T, Sapienza C. The role of voice therapy in the management of paradoxical vocal fold motion, chronic cough and laryngospasm. Otolaryngol Clin North Am 2010; 43:73-83.
83 Vertigan AE, Gibson PG. The role of speech pathology in the management of patients with chronic refractory cough. Lung 2012; 190:35-40.
84 Morrison MD, Rammage LA, Belisle GM, et al. Muscular tension dysphonia. J Otolaryngol 1983; 12:302-6.
85 Angsuwarangsee T, Morrison M. Extrinsic laryngeal muscular tension in patients with voice disorders. J Voice 2002; 16:333-43.
86 Morrison M, Rammage L. Muscle misuse voice disorders: description and classification. Acta Otolaryngol (Stockh) 1993; 113:428-34.
87 Nathadwarawala K, Nicklin J, Wiles C. A timed test of swallowing capacity for neurological patients. J Neurol Neurosurg Psychiatry 1992; 55: 822-55.
88 Dicpinigaitis P, Dobkin J, Rauf K, et al. Inhibition of capsaicin-induced cough by the gamma-aminobutyric acid agonist baclofen. J Clin Pharmacol 1998; 38:364-7.
89 Bastian R, Vaidya A, Delsupehe K. Sensory neuropathic cough: a common and treatable cause. Otolaryngol Head Neck Surg 2006; 135:17-21.
90 Norris BK, Schweinfurth JM. Management of recurrent laryngeal sensory neuropathic symptoms. Ann Otol Rhinol Laryngol 2010; 119:188-91.
91 Lee B, Woo P. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol 2005; 114:253-7.
92 Mintz S, Lee JK. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am J Med 2006; 119:e13-5.
93 Dicpinigaitis PV, Rauf K. Treatment of chronic, refractory cough with baclofen. Respiration 1998; 65:86-8.
94 Xu X-H, Yang Z-M, Chen Q, et al. Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough. World J Gastroenterol 2013; 19:4386-92.
95 Chung KF. NMDA and GABA receptors as potential targets in cough hypersensitivity syndrome. Curr Opin Pharmacol 2015; 22:29-36.
96 Rytila P, Ghaly L, Varghese S, et al. Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function. Eur Respir J 2008; 32:989-96.
97 Ribeiro M, Pereira CA, Nery LE, et al. High-dose inhaled beclomethasone treatment in patients with chronic cough: a randomized placebo controlled study. Ann Allergy Asthma Immunol 2007; 99:61-8.
98 Pizzichini M, Pizzichini E, Parameswaran K, et al. Nonasthmatic chronic cough: No effect of treatment with an inhaled corticosteriod in patients without sputum eosinophilia. Can Respir J 1999; 6:323-30.
99 Johnstone KJ, Chang AB, Fong KM, et al. Inhaled corticosteroids for subacute and chronic cough in adults. Cochrane Database Syst Rev 2013; 3:CD009305.
100 Shaheen NJ, Crockett SD, Bright SD, et al. Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo controlled study. Aliment Pharmacol Ther 2011; 33:225-34.
101 Holmes PW, Barter CE, Pierce RJ. Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection. Respir Med 1992; 86:425-9.
102 Shembel AC, Rosen CA, Zullo TG, et al. Development and validation of the cough severity index: a severity index for chronic cough related to the upper airway. Laryngoscope 2013; 123:1931-6.
103 Birring S, Prudon B, Carr A, et al. Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire. Thorax 2003; 58:339-43.
104 Birring S, Fleming T, Matos S, et al. The Leicester cough monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respir J 2008; 31:1013-8.
105 Molassiotis A, Bryan G, Caress A, et al. Pharmacological and nonpharmacological interventions for cough in adults with respiratory and non-respiratory diseases: a systematic review of the literature. Respir Med 2010; 104:934-44.
106 Eckerblad J, Todt K, Jakobsson P, et al. Symptom burden in stable COPD patients with moderate or severe airflow limitation. Heart Lung 2014; 43:351-7.
107 Hope-Gill BDM, Hilldrup S, Davies C, et al. A study of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168:995-1002.
108 Ryerson CJ, Abbritti M, Ley B, et al. Cough predicts prognosis in idiopathic pulmonary fibrosis. Respirology 2011; 16:969-75.
109 Brown KK. Chronic cough due to chronic interstitial pulmonary diseases: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1suppl):180S-5S.
110 Lalloo UG, Lim S, DuBois R, et al. Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease. Eur Respir J 1998; 11:702-5.
111 Raghu G, Anstrom K, King TJ, et al. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968-77.
112 Abdulqawi R, Dockry R, Holt K, et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 2015; 385:1198-205.
113 Morice AH, Fontana GA, Belvisi MG, et al. ERS guidelines on the assessment of cough. Eur Respir J 2007; 29:1256-76.
114 Kohno S, Ishida T, Uchida Y, et al. The Japanese Respiratory Society guidelines for management of cough. Respirology 2006;11:S135-86.